Let's Win Pancreatic Cancer 💜
@letswinpc
Let’s Win is your guide to hope and action. Our mission is to guide pancreatic cancer patients with vital information for better outcomes. 💜
Episode 3 of the Let's Win and @PanCAN's #PancChat Podcast is live! Listen as Dr. Anirban Maitra (@Aiims1742) of @MDAnderson @nyulangone and Dr. Michael Goggins of @HopkinsMedicine discuss #PancreaticCancer Risk Factors with @AlisynCamerota. share.transistor.fm/s/7c8193db
Bill Shrieves was diagnosed with stage IV pancreatic cancer in 2011. FOLFIRINOX knocked it back—11 rounds, no evidence since. He’s now >5 years cancer-free. His mindset? “I have pancreatic cancer, but it doesn’t have me.” 🔗 letswinpc.org/survivor-stori…
Dr. Anup Kasi provides in-depth information and answers questions about qualifying for pancreatic cancer clinical trials. bit.ly/3XPvGMT
A new clinical trial is testing a triple-drug combo (nab-paclitaxel, gemcitabine, and cisplatin) for metastatic pancreatic cancer patients with BRCA1/2 or PALB2 mutations. If you've had previous treatments but not cisplatin, this could be for you. bit.ly/4bkSJDn
Ep. 3 of the new PancChat Podcast, a collaborative effort between @PanCAN and @LetsWinPC, is here, and it’s a must-listen! 🎧 @Aiims1742 @MDAndersonNews @nyulangone @Perlmutter_CC @HopkinsMedicine @AlisynCamerota
In this episode of 🎙️ PancChat, host @AlisynCamerota is joined by Dr. Michael Goggins and @Aiims1742 for an in-depth discussion about the risk factors for #pancreaticcancer. Together, they explore lifestyle, inherited, and disease-related risks, explain how genetics and new-onset…
Artificial intelligence can have many benefits for patients and caregivers, organizing complex information, but it must be used properly. bit.ly/3TWkkUc
This is an excellent meeting! The inaugural MD Education GI Cancers Meeting. Outstanding presentation on later line HCC therapy by Dr. Richard Finn from UCLA. Put this meeting on your calendar next year and check their other meetings. @_MDEducation md-education.com/gi-cancers-us-…
NCI Interim Funding Policy: “With these considerations, we expect to fund through the 4th percentile for those established investigator applications.” “It is expected that funds will be available to reach the 10th percentile for those Early Stage Investigator applications.” 😢
The human proteome and organ age clocks across the lifespan, a tour de force report @CellCellPress cell.com/cell/abstract/…
👇🏾 Incredibly harmful for our cancer patients who rely on novel clinical trials with new drugs that can be potentially effective against their disease.
FDA’s cancer review teams have lost about 1/3 of the medical review staff that oversee products for breast and gynecological cancers and the malignant heme group may lose about 2/3 of its medical review staff—all to voluntary resignations clustered among more seasoned reviewers
A big big thank you to our 4 great ASCO LDP mentors, who choose to dedicate an enormous amount of time & energy to this program. We appreciate all of their support! @montypal, @DrMarkham, Nasser Hanna & Piyush Srivastava 🙏
Exciting progress in treating neuroendocrine tumors (#NET) and #pancreaticcancer! Watch this Seminars and Tumor Board activity to explore the latest clinical data and treatment strategies. @Ahn_Daniel_Onc @letswinpc @netcanceraware bit.ly/44yk0RM
Signed out my last #GIPath biopsy at @MDAndersonNews. What a surreal feeling after 12 years. 🔬 Thank you to all my colleagues to whom I reached out for consultations. Signing out biopsies at a cancer center requires a distinct mindset than in a “general” academic setting. 😅
Excited to be attending #PancreasFest25 in Pittsburgh to speak abt the increasingly important topic of #EarlyOnset #PancreaticCancer #pancsm, & honored to be included in a wonderful roster of pancreatologists & disease experts @SylvesterCancer @umiamimedicine @PanCAN @letswinpc
New @iScience_CP paper by @NinaSteele17 @Pasca_Lab Primary and metastatic cellular landscapes in human #PancreaticCancer cell.com/iscience/fullt… Signatures of pancreatic cancer metastases associated T cells (exhausted), macrophages (complement pathway) and fibroblasts (UPP1 +).
A really important resource in @CCR_AACR from @NinaSteele17 who deserves credit for collating all of these datasets in one place (besides her own de novo single cell and spatial transcriptomics data). Human #PancreaticCancer single cell atlas reveals association of CXCL10+…
Adding to long standing thread on single cell RNA sequencing papers in #PancreaticCancer, an important atlas by @NinaSteele17 @Pasca_Lab: Human Pancreatic Cancer Single-Cell Atlas Reveals Association of CXCL10+Fibroblasts and Basal Subtype Tumor Cells aacrjournals.org/clincancerres/…
In 3 prospective cohorts comprised of 2.2 million individuals from UK and China, #Diabetes increases the risk of #LiverCancer #PancreaticCancer #BladderCancer New @JNCI_Now study: academic.oup.com/jnci/advance-a…
Two B2B preclinical papers published in @CR_AACR - one by @cjder23 @derlabunc & the other by @KathleenMulvan4 - combining MTA-cooperative PRMT5 inhibitors with KRAS inhibitors in MTAP-deleted cancers. Coming to the clinic soon! aacrjournals.org/cancerres/arti… aacrjournals.org/cancerres/arti…